Get the Weekly Intelligence Brief — top committee picks every Sunday.
HD · NYSE · STOCK

Home Depot (HD) Stock Analysis

Consumer Cyclical Updated August 23, 2026
$335.71
52W $289.10 – $426.75
50/100
$334.64B
23.4
0.96
AI Committee Verdict
Watch
50/100
Conviction: Moderate · 67% agreement · 6 analysts
+5.3%
-1.3%
4.18:1
Moderate

Is HD Bullish or Bearish?

Mixed. Innellis AI committee rates Home Depot (The) (HD) Watch with a composite score of 50/100 , based on 6 analysts with 67% agreement. Last updated August 23, 2026.

What Would Change This View

Upgrade to Buy
Requires a committee score of 60.0 — +10.14 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Reduce
Requires the score to fall below 40.0 — -9.86 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. Macro Analyst sees a compelling case. Risk Analyst remains cautious — high leverage (debt-to-equity 4.35) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • ROE of 113.3% shows genuine earnings power backing the valuation — Value
  • Dividend yield of 2.7% pays you to wait — Value
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
Bear Case
  • Price-to-book of 29.4x prices in significant intangible value — Value
  • Debt-to-equity of 4.35 adds balance-sheet risk to the value case — Value
  • EPS declining -4.5% YoY despite any revenue growth — Growth
  • MACD histogram negative -- bearish momentum — Technical
  • High leverage (debt-to-equity 4.35) amplifies downside in a stress scenario — Risk
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of August 23, 2026
Overall Committee Score
50/100
Agreement
67%
Analysts
6
Conviction
Moderate
Sector Rank
Top 90%
of 178 Consumer Cyclical peers
Value Analyst neutral
50 / 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 113.3% shows genuine earnings power backing the valuation
− Price-to-book of 29.4x prices in significant intangible value
Growth Analyst neutral
48 / 100 · High confidence
Moderate growth -- present but not remarkable
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
− EPS declining -4.5% YoY despite any revenue growth
Technical Analyst neutral
48 / 100 · High confidence
Mixed or range-bound price action
− MACD histogram negative -- bearish momentum
Risk Analyst bearish
30 / 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− High leverage (debt-to-equity 4.35) amplifies downside in a stress scenario
Macro Analyst bullish
65 / 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst neutral
58 / 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager neutral
45 / 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 3069.37)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 49.9 to 49.9.

Comparing 2026-08-22 to 2026-08-23 (1 day apart).

Technical Analysis

RSI (14)
41.2
Neutral
MACD Histogram
-1.471
Bearish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Hh Hl
Support
$331.46
Resistance
$353.55
Bollinger %B
0.27
Inside Bands
Price vs Moving Averages
EMA 9
$339.98 Below
EMA 21
$340.98 Below
EMA 50
$338.47 Below
EMA 200
$346.36 Below

Fundamental Analysis

Valuation
55
Growth
69
Profitability
69
Financial Health
12
Cash Flow
70
Valuation
P/E Ratio 23.4×
P/B Ratio 20.08×
PEG Ratio -8.04
Dividend Yield 2.76%
52W High $426.75
52W Low $289.10
Quality & Growth
ROE 11048.1%
ROA 1347.0%
Gross Margin 3320.6%
Operating Margin 1242.6%
Revenue Growth YoY
Debt / Equity 3.48
AI Fundamental Assessment
P/E ratio of 23.4 (inexpensive relative to a 15-40x range); Price-to-book of 20.1x; PEG ratio of -8.0 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 110.5%; Return on assets of 13.5%; Net margin of 8.4%; Gross margin of 33.2%; Current ratio of 1.08 (tight short-term liquidity); Debt-to-equity of 3.48; Free cash flow per share is positive (15.19); Most recent quarter beat estimates by 0.9%; EPS growth accelerating (+26.1% -> +43.4% QoQ); Average YoY EPS growth of 5.1%; Analyst estimates rising over recent quarters
Get the Full HD Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime